Krystal Biotech (KRYS) Treasury Shares (2021 - 2026)
Krystal Biotech (KRYS) reported Treasury Shares of $43536.0 for Q1 2026, down 87.52% on a YoY basis from $348757.0 in Q1 2025, and down 22.6% sequentially from $56250.0 in Q4 2025.
Krystal Biotech (KRYS) Treasury Shares (2021 - 2026) Analysis & Trends
Krystal Biotech (KRYS) has 6 years of Treasury Shares data on file, last reported at $43536.0 in Q1 2026.
- For the quarter ending Q1 2026, Treasury Shares fell 87.52% year-over-year to $43536.0; the trailing twelve-month figure through Mar 2026 stood at $43536.0 (down 87.52% YoY), and the FY2025 full-year result was $56250.0, down 81.74% from the prior year.
- Treasury Shares retreated to $43536.0 in Q1 2026, from $56250.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $348757.0 in Q1 2025 to a low of $22200.0 in Q1 2024.
- A 5-year average of $130347.9 and a median of $70350.0 in 2022 frame the typical range for Treasury Shares.
- Across the five-year window, Treasury Shares soared 1470.98% in 2025 and sank 87.52% in 2026, its largest moves.
- Tracing KRYS's Treasury Shares over 5 years: stood at $66600.0 in 2022, then retreated by 24.92% to $50000.0 in 2023, then surged by 516.19% to $308096.0 in 2024, then slumped by 81.74% to $56250.0 in 2025, then decreased by 22.6% to $43536.0 in 2026.
- Business Quant data shows KRYS's Treasury Shares at $43536.0 in Q1 2026, $56250.0 in Q4 2025, and $56250.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Krystal Biotech | 9.59 Bn | 8.77 Bn | 110.08 Mn | 43,536.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43,536.00 |
| Mar 31, 2026 | 43,536.00 |
| Dec 31, 2025 | 56,250.00 |
| Dec 31, 2025 | 56,250.00 |
| Sep 30, 2025 | 56,250.00 |
| Sep 30, 2025 | 56,250.00 |
| Jun 30, 2025 | 338,878.00 |
| Jun 30, 2025 | 338,878.00 |
| Mar 31, 2025 | 348,757.00 |
| Mar 31, 2025 | 348,757.00 |
| Dec 31, 2024 | 308,096.00 |
| Dec 31, 2024 | 308,096.00 |
| Sep 30, 2024 | 137,500.00 |
| Sep 30, 2024 | 137,500.00 |
| Jun 30, 2024 | 137,500.00 |
| Jun 30, 2024 | 137,500.00 |
| Mar 31, 2024 | 22,200.00 |
| Mar 31, 2024 | 22,200.00 |
| Dec 31, 2023 | 50,000.00 |
| Dec 31, 2023 | 50,000.00 |